vaharrison@csnsf.org

Migraine drug is first to tackle debilitating early symptoms

by Suzi Wilson | May 12, 2025 | Uncategorized | 0 comments

Author

Nature, Published online: 12 May 2025; doi:10.1038/d41586-025-01503-3

Results from a phase III clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent pre-headache fatigue and light sensitivity.

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.